Key result
Malignant brain tumors linked to ~6-fold higher non-cancer mortality versus the general population.
Why the study?
Research on mortality outcomes and non-cancer-related causes of death in patients with malignant brain tumors remains limited.
Do patients with malignant brain tumors have an increased risk of non-cancer-related mortality compared to the general population?
Cohort (n=85,915)
Yes
Do patients with malignant brain tumors have an increased risk of non-cancer-related mortality compared to the general population?
Patients with malignant brain tumors face a significantly elevated risk of non-cancer mortality, particularly from cardiovascular and cerebrovascular diseases, highlighting the need for comprehensive survivorship care.
Background Research on mortality outcomes and non-cancer-related causes of death in patients with malignant brain tumors remains limited. This study aims to identify the prevalence of non-cancer-related causes of death after brain cancer (BC) diagnosis. Methods Data of patients diagnosed with BC in the USA between 2000 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database were retrieved and analyzed. Standardized mortality ratios (SMRs) were calculated for all the reported causes of death. Results A total of 59,663 deaths were reported during the follow-up period. The highest number of fatalities (34,677) occurred within the first year following BC diagnosis. BC-attributable deaths were the leading cause of mortality (55,482; 93%), followed by non-cancer deaths (3888; 6.5%). BC patients had an increased risk of non-cancer attributable deaths (SMR = 6.12; 95% CI 5.93–6.31) including heart diseases ( N = 938; SMR = 5.3; 95% CI 4.96–5.65), cerebrovascular diseases ( N = 453; SMR = 13.17; 95% CI 11.98–14.44), accidents and adverse effects ( N = 227; SMR = 2.97; 95% CI 2.6–3.39), and septicemia ( N = 155; SMR = 13.39; 95% CI 11.36–15.67). Conclusion Compared to the general population, BC patients had a statistically significant higher risk of death from most of the reported causes.
No takes yet. Share an insight, caveat, or question.
Ashry et al. (2025) conducted a cohort in Malignant brain tumors (n=85,915). Malignant brain tumor diagnosis vs. General US population was evaluated on Non-cancer attributable deaths (SMR 6.12, 95% CI 5.93-6.31, p=<0.05). Patients with malignant brain tumors had a significantly increased risk of non-cancer attributable deaths compared to the general population (SMR 6.12).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: